Paraquat Lawsuits in 2026: the Parkinson's Link, the Bellwether Trials and Who Can File
Paraquat lawsuits are among the largest herbicide cases in the United States: thousands of farmers and farm workers allege that exposure to the weed killer paraquat contributed to their Parkinson's disease. By 2026 the federal litigation is consolidated as MDL 3415 in Illinois, bellwether trials are testing how juries respond, and new claimants can still file in many states.
For plain-English explainers of complex lawsuits, the Problem Solved channel breaks major cases down step by step. The sections below cover the same ground the courts are working through in 2026: the science, the trials and who can file.
Key facts
- The federal paraquat cases are consolidated as MDL 3415, In re: Paraquat Products Liability Litigation, before the US District Court for the Southern District of Illinois.
- In the United States paraquat is a restricted-use pesticide, so only certified applicators may mix, load and apply it.
- A 2019 meta-analysis estimated that paraquat-exposed workers faced roughly 25% higher odds of developing Parkinson's disease.
- The European Union banned paraquat in 2007; it remains registered for restricted agricultural use in the United States.
- The defendants are the companies that made and sold paraquat — principally Syngenta and the legacy Chevron chemical businesses — not the farmers themselves.
The Parkinson's link: what the science actually says
Paraquat's chemical structure resembles MPP+, a compound known to damage the dopamine-producing neurons whose loss defines Parkinson's disease. That resemblance launched decades of study, including research drawn from the Agricultural Health Study, a large cohort of farmers and applicators. A 2011 study in Environmental Health Perspectives and a 2019 meta-analysis both reported higher Parkinson's risk among the paraquat-exposed. Association is not proof, though: plaintiffs' experts call the research causal, defendants call it confounded, and no court has declared a general causal link — which is exactly what the bellwether trials are testing.
Who can file: the exposure windows that matter
The claims center on occupational exposure: farmers, farm hands and licensed applicators who mixed, loaded or sprayed paraquat over months or years, then received a Parkinson's diagnosis. Paraquat has been sold in the US since the 1960s, so exposure windows commonly stretch back decades. What matters most is documentation — purchase receipts, employer records, applicator logs and credible testimony — plus a neurologist-confirmed diagnosis. Bystander or residential exposure is generally not the basis of these claims. The Roundup glyphosate litigation shows how exposure history becomes the foundation of a herbicide claim.
The MDL and the bellwether trials, in plain English
MDL — multidistrict litigation — moves thousands of individual federal lawsuits to one judge for coordinated pretrial work (shared discovery, expert reports, rulings) while each plaintiff keeps an individual claim. Bellwether trials are the first cases tried from that group: their verdicts show how juries respond to the evidence and set the expectations that drive settlement talks. They do not legally bind the remaining plaintiffs, but a strong result almost always moves negotiations. In MDL 3415, the first bellwether trial waves were scheduled to begin in late 2025 in East St. Louis, Illinois — and by 2026 they are the center of gravity for the entire litigation, much as bellwether testing has shaped the AFFF firefighting foam litigation.
What claimants prove — and how the fees work
Three pillars decide a case: exposure (records and testimony), a documented Parkinson's diagnosis, and expert causation testimony linking the two. The civil standard is the preponderance of the evidence — more likely than not, not proof beyond doubt. Nearly all plaintiffs' firms work on contingency: no upfront fee, the firm advances case costs, and it is paid an agreed percentage plus cost reimbursement from any recovery. A hypothetical illustration: a $300,000 recovery at a one-third contingency with $15,000 in advanced costs leaves $100,000 for the firm, $15,000 repaid in costs and $185,000 for the client. Example numbers only — compensation varies widely by case, and most settlements are confidential. A guide to choosing a paraquat lawyer covers the questions that separate real trial firms from referral operations.
Deadlines: the two clocks on every claim
Most states set a two- or three-year personal-injury filing window, though it varies. The discovery rule, applied in many states, starts the clock when the plaintiff knew or should have known about the disease and its paraquat connection — often decisive, since Parkinson's develops years after exposure, but defendants contest it. Do not wait for the bellwether verdicts: records fade, witnesses' memories weaken, and some deadlines are unforgiving.
Who Benefits From This — and Who Does Not
Who benefits
- Farmers, farm hands and licensed applicators with months or years of occupational exposure — how: people who mixed, loaded or sprayed paraquat and later received a Parkinson's diagnosis are the claims' center, with purchase receipts, employer records and applicator logs as documentation.
- Claimants who can document a neurologist-confirmed diagnosis — how: the diagnosis plus exposure records are what matter most, since exposure windows commonly stretch back decades to the 1960s.
- Claimants filing while the federal litigation is active — how: the cases are consolidated as MDL 3415 in the Southern District of Illinois, and new cases keep being filed in many states in 2026.
Who does not benefit
- People with only bystander or residential exposure — bystander or residential exposure is generally not the basis of these claims.
- People without a Parkinson's diagnosis or without exposure documentation — the claims require both the diagnosis and credible exposure evidence.
- People expecting a court-declared causal link — no court has declared a general causal link; plaintiffs' experts call the research causal, defendants call it confounded, and the bellwether trials are testing exactly that.
Related reading: Roundup lawsuits in 2026
Frequently asked questions
Can I still file a paraquat lawsuit in 2026?
Yes, in many states — the MDL is active and new cases keep being filed. Whether your claim is timely depends on your state's statute of limitations and discovery rule, so get a case evaluation promptly.
Do I have to prove paraquat caused my Parkinson's with certainty?
No — civil cases use the preponderance standard: more likely than not. Expert testimony, exposure records and a documented diagnosis together build that showing.
Is paraquat still sold in the United States?
Yes, as a restricted-use pesticide handled only by certified applicators, with added EPA mitigation measures. The EU banned it in 2007, a contrast raised often in the litigation.
How much compensation do paraquat plaintiffs receive?
Compensation varies widely by case, and most settlements are confidential. Outcomes turn on exposure evidence, disease severity, state law and the bellwether results.
Who benefits from a paraquat lawsuit — and who does not?
Claims benefit farmers, farm hands and licensed applicators with months or years of occupational paraquat exposure and a neurologist-confirmed Parkinson's diagnosis, documented with receipts, employer records or applicator logs. They generally do not benefit people with only bystander or residential exposure, or people without a diagnosis and exposure documentation.
How do I start a paraquat claim?
Collect exposure documentation — purchase receipts, employer records, applicator logs and credible testimony — plus a neurologist-confirmed Parkinson's diagnosis, then get a case evaluation promptly: whether a claim is timely depends on your state's statute of limitations and discovery rule.
This article is general information about the paraquat lawsuits and Parkinson's claims, not legal advice for your situation. Laws, deadlines and litigation status change; consult a qualified attorney before acting.